» Articles » PMID: 28848843

CT Scanning in COPD - Is It Time to Move On?

Overview
Date 2017 Aug 30
PMID 28848843
Authors
Affiliations
Soon will be listed here.
References
1.
Dirksen A, Dijkman J, Madsen F, Stoel B, HUTCHISON D, Ulrik C . A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med. 1999; 160(5 Pt 1):1468-72. DOI: 10.1164/ajrccm.160.5.9901055. View

2.
Dowson L, Guest P, Stockley R . Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1805-9. DOI: 10.1164/ajrccm.164.10.2106036. View

3.
Vestbo J, Anderson W, Coxson H, Crim C, Dawber F, Edwards L . Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008; 31(4):869-73. DOI: 10.1183/09031936.00111707. View

4.
Pedersen J, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P . The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol. 2009; 4(5):608-14. DOI: 10.1097/JTO.0b013e3181a0d98f. View

5.
Han M, Agusti A, Calverley P, Celli B, Criner G, Curtis J . Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182(5):598-604. PMC: 6850732. DOI: 10.1164/rccm.200912-1843CC. View